161 related articles for article (PubMed ID: 10536012)
21. Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Wang XS; Fang HL; Chen Y; Liang SS; Zhu ZG; Zeng QY; Li J; Xu HQ; Shao B; He JC; Hou ST; Zheng RY
Eur J Pharmacol; 2014 Aug; 736():70-6. PubMed ID: 24797785
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
[TBL] [Abstract][Full Text] [Related]
23. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
24. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
[TBL] [Abstract][Full Text] [Related]
25. Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.
Martín R; Hernández M; Córdova C; Nieto ML
Br J Pharmacol; 2012 Jul; 166(5):1708-23. PubMed ID: 22260389
[TBL] [Abstract][Full Text] [Related]
26. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
[TBL] [Abstract][Full Text] [Related]
27. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis.
Achiron A; Miron S; Lavie V; Margalit R; Biegon A
J Neuroimmunol; 2000 Jan; 102(1):26-31. PubMed ID: 10626663
[TBL] [Abstract][Full Text] [Related]
28. The complexicity of cytokine treatment in ongoing EAE induced with MBP peptide 68-86 in Lewis rats.
Xu LY; Ishikawa M; Huang YM; Levi M; van der Meide PH; Wahren B; Link H; Xiao BG
Clin Immunol; 2000 Apr; 95(1 Pt 1):70-8. PubMed ID: 10794434
[TBL] [Abstract][Full Text] [Related]
29. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human PDCD5 (rhPDCD5) protein is protective in a mouse model of multiple sclerosis.
Xiao J; Liu W; Chen Y; Deng W
J Neuroinflammation; 2015 Jun; 12():117. PubMed ID: 26068104
[TBL] [Abstract][Full Text] [Related]
31. Butylphthalide ameliorates experimental autoimmune encephalomyelitis by suppressing PGAM5-induced necroptosis and inflammation in microglia.
Wang Y; Bi Y; Xia Z; Shi W; Li B; Li B; Chen L; Guo L
Biochem Biophys Res Commun; 2018 Feb; 497(1):80-86. PubMed ID: 29407174
[TBL] [Abstract][Full Text] [Related]
32. Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair.
Mohajeri M; Sadeghizadeh M; Najafi F; Javan M
Neuropharmacology; 2015 Dec; 99():156-67. PubMed ID: 26211978
[TBL] [Abstract][Full Text] [Related]
33. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
34. Nobiletin attenuates inflammation via modulating proinflammatory and antiinflammatory cytokine expressions in an autoimmune encephalomyelitis mouse model.
Yarim GF; Yarim M; Sozmen M; Gokceoglu A; Ertekin A; Kabak YB; Karaca E
Fitoterapia; 2022 Jan; 156():105099. PubMed ID: 34896483
[TBL] [Abstract][Full Text] [Related]
35. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
36. Treatment with a hybrid between the synapsin ABC domains and the B subunit of E. coli heat-labile toxin reduces frequency of proinflammatory cells and cytokines in the central nervous system of rats with EAE.
Bibolini MJ; Scerbo MJ; Roth GA; Monferran CG
Neuroscience; 2014 Sep; 277():217-28. PubMed ID: 25020120
[TBL] [Abstract][Full Text] [Related]
37. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
[TBL] [Abstract][Full Text] [Related]
38. Arctigenin Suppress Th17 Cells and Ameliorates Experimental Autoimmune Encephalomyelitis Through AMPK and PPAR-γ/ROR-γt Signaling.
Li W; Zhang Z; Zhang K; Xue Z; Li Y; Zhang Z; Zhang L; Gu C; Zhang Q; Hao J; Da Y; Yao Z; Kong Y; Zhang R
Mol Neurobiol; 2016 Oct; 53(8):5356-66. PubMed ID: 26440666
[TBL] [Abstract][Full Text] [Related]
39. Differential role of TNF-alpha and IFN-gamma in the brain of rats with chronic relapsing autoimmune encephalomyelitis.
Tanuma N; Shin T; Kogure K; Matsumoto Y
J Neuroimmunol; 1999 Apr; 96(1):73-9. PubMed ID: 10227426
[TBL] [Abstract][Full Text] [Related]
40. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
